Latest Dabigatran Stories
Largest observational study of a newer oral anticoagulant, with more than 134,000 elderly patients, published in Circulation RIDGEFIELD, Conn., Nov. 3, 2014 /PRNewswire/ -- A U.S.
The Firm is evaluating Xarelto lawsuits on behalf of individuals who experienced uncontrollable internal bleeding, blood clots, and other serious complications, allegedly due to their use of the
Boehringer Ingelheim launches comprehensive support resources for people with idiopathic pulmonary fibrosis RIDGEFIELD, Conn., Oct.
Company to make OFEV available to IPF community within 10 days, along with comprehensive patient support resources RIDGEFIELD, Conn., Oct.
The Firm is evaluating potential legal claims on behalf of individuals who allegedly suffered uncontrollable internal bleeding and other serious side effects due to the use of the blood thinning
Case Funding Company says recent $650MM settlement of approximately 4K filed cases in both state and federal courts over blood thinner, amounts to an average Pradaxa settlement amount or settlement
As Pradaxa Lawsuit Claims Continue Boehringer Ingelheim Conducts Clinical Trials On Idarucizumab, A Potential Reversal Agent To Pradaxa Columbus, OH (PRWEB)
Wright & Schulte LLC Continues To Investigate Complaints That Janssen Pharmaceuticals Did Not Disclose The Lack of An Effective Means To Treat Uncontrolled Bleeding In Patients Taking Xarelto
-Direct Oral Anticoagulant Measurement, Automated on ACL TOP® Family of Hemostasis Testing Systems- BEDFORD, Mass., Sept.
The Firm is evaluating Xarelto lawsuits on behalf of patients who suffered uncontrollable internal bleeding, stroke, deep vein thrombosis, pulmonary embolism, or death, allegedly due to their
- An armed gangster.